Corvus Pharmaceuticals CRVS Return on invested capital

Return on invested capital at other companies

Eli LillyLLY

39.7%+10.3pp

Regeneron PharmaceuticalsREGN

10.3%-1.5pp

AbbVieABBV

17.1%—

Aclaris TherapeuticsACRS

-79.9%-22.6pp

Cullinan Therapeutics, Inc.CGEM

-58%+22.6pp

Nektar TherapeuticsNKTR

-35.4%-12.2pp

FAQ

What is Corvus Pharmaceuticals's return on invested capital?

Corvus Pharmaceuticals (CRVS) reported return on invested capital of -38.8% in Q1 2026.

How has Corvus Pharmaceuticals's return on invested capital changed year-over-year?

Corvus Pharmaceuticals's return on invested capital increased by 55.0% year-over-year, from -86.2% to -38.8%.

What is the long-term trend for Corvus Pharmaceuticals's return on invested capital?

Over 5 years (2020 to 2025), Corvus Pharmaceuticals's return on invested capital has grown at a 8.6% compound annual growth rate (CAGR), from -68.8% to -104.2%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.